Notably, high Ki-67 positivity has been correlated with higher prognostic indices, while Ki-67-negative patients demonstrated higher overall and disease-free survival rates, indicating the potential utility of Ki-67 as a predictive prognostic indicator for DLBCL [23]. The gene discussed is MKI67; the disease is diffuse large B-cell lymphoma.